Medication info
Apenra Tablets

Apenra Tablets

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Korea Nelson Pharmaceutical Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablets
Packaging
300 tablets per bottle, 30 tablets per bottle
Approval status
Active

MFDS item code 200805810 · Notified 2008.05.26 · Insurance code 656701470

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Subsequent doses should be given at intervals of at least 6 hours, and the dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment should be continued. Older adults Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and over, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, an additional dose of this drug is not needed after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: An initial dose of 2 tablets; subsequent doses should be given at intervals of at least 6 hours, and the dose should not exceed 8 tablets per day.

Ingredients

Manufacturer
Korea Nelson Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate pain
  • severe pain
  • acute pain
  • chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Subsequent doses should be given at intervals of at least 6 hours, and the dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment should be continued. Older adults Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and over, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, an additional dose of this drug is not needed after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: An initial dose of 2 tablets; subsequent doses should be given at intervals of at least 6 hours, and the dose should not exceed 8 tablets per day.

Precautions

This medication may cause liver damage if taken by individuals who regularly consume more than three drinks a day, so it should be discussed with a doctor or pharmacist. The acetaminophen component has been rarely associated with severe skin reactions, so if a rash or hypersensitivity occurs, discontinue use immediately. The tramadol component increases the risk of seizures if the recommended dose is exceeded, and the risk is even higher when combined with certain antidepressants or narcotics. Patients with a history of seizures or epilepsy should be especially cautious while taking this medication. In addition, severe allergic reactions like anaphylaxis have been reported very rarely, so any unusual symptoms should be reported to healthcare providers immediately. Patients with acute and severe bronchial asthma face a risk of respiratory depression, and should only be administered in a monitored environment. This medication may cause sedation, respiratory depression, or coma if taken with central nervous system depressants or alcohol; thus, co-administration should be avoided or used very cautiously. Patients with increased intracranial pressure or head injuries may experience worsening symptoms due to respiratory depression, so caution is required. Tramadol can lead to physical and psychological dependence, so long-term use requires careful monitoring for signs of dependency. Patients with impaired liver function face a higher risk of hepatotoxicity with this medication, so they must consult a doctor before use, ensuring they do not exceed recommended acetaminophen levels. For ultra-rapid metabolizers of CYP2D6, increased plasma levels of active metabolites may heighten the risk of respiratory depression, necessitating dosage adjustment and monitoring. This medication should not be administered to children under 12 years of age or to adolescents under 18 years who have undergone tonsillectomy or adenoidectomy. In cases of sleep apnea or hypoxia, symptoms may worsen after taking this medication, so changes in symptoms should be closely monitored. Patients at risk for hyponatremia should regularly check their blood sodium levels while taking this medication. This medication is contraindicated in certain patient populations, especially those with hypersensitivity to the components, severe respiratory depression, head injuries, or those taking MAO inhibitors. When taking this medication, do not exceed the recommended dose, and do not combine it with other acetaminophen or tramadol formulations. Sudden discontinuation of this medication may lead to withdrawal symptoms, so dosage should be tapered off gradually when stopping. During treatment, closely monitor for symptoms of seizures, allergic reactions, or respiratory difficulties. Also, be cautious while driving or operating machinery, as drowsiness or dizziness may occur. In cases of overdose, serious respiratory depression, seizures, or liver damage may occur, so emergency treatment should be sought immediately.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremor, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, diaphoresis, urinary disturbance, erectile dysfunction, myasthenia, chest pain, emotional abnormality, chills, chest discomfort, malaise, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, elevated serum creatinine, anaphylaxis, unstable emotions, delirium, suicidal ideation, muscular hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prothrombin time increase, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, fatigue glutamate acidosis, high anion gap metabolic acidosis, fixed rash, myasthenia, fever, edema, rigidity, syncope, congestive heart failure, confusion, aggravated migraine, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urine retention, increased urination, renal dysfunction, oliguria, increased sweating, urticaria, dysphagia, tongue swelling, hypersalivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic bowel obstruction, hiccups, cholecystitis, drowsiness, insomnia, loss of appetite, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, palpitations, arrhythmias, aggravated hypertension, aortic stenosis, hematochezia, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, dizziness, confusion, dyspnea, disorientation, multiple organ failure, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, upper respiratory syndrome, mouth sores, agitation, irritability, hyperactivity, gastrointestinal symptoms, panic attack, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system responses, urticaria, rash, bronchospasm, toxic skin necrosis, allergic reactions, convulsions, serotonin syndrome, opioid-induced hyperalgesia, withdrawal symptoms, respiratory arrest, QT prolongation, hypersomnia, cardiac arrest, death, liver failure, renal tubular necrosis, hypotension, extreme fatigue, loss of appetite, weight loss, acute or chronic adrenal insufficiency

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent air exposure. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablets

Package unit

300 tablets per bottle, 30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.